期刊文献+

对1例Castleman病患者进行诊治的体会

下载PDF
导出
摘要 Castleman病(CD病)是一种以原因不明的淋巴结肿大为主要特征的慢性多克隆性淋巴组织增生性疾病。该病在临床上较为少见。本文对1例CD病患者的诊治过程进行分析,以期为床上诊治此病提供参考。
出处 《当代医药论丛》 2020年第16期185-186,共2页
  • 相关文献

参考文献4

二级参考文献43

  • 1Rovers MM,Schilder AG,Zielhuis GA,Rosenfeld RM,张江平,杨妙丽,张全安.中耳炎[J].国外医学(耳鼻咽喉科学分册),2005,29(3):141-143. 被引量:428
  • 2江蓓,杨向东,宋强,胡昭.以肾损害为首发表现的Castleman病误诊1例分析并文献复习[J].中国误诊学杂志,2007,7(25):5967-5969. 被引量:3
  • 3Seo S,Yoo C,Yoon DH,et al. Clinical features and outcomes in patients with human immunodeficiency virus-negative,multicentric Castleman’s disease:a single medical center experience[J].Blood Res,2014,49(4):253-258.
  • 4Kawabata H,Kadowaki N,Nishikori M,et al. Clinical features and treatment of multicentric castleman’s disease:a retrospective study of 21 Japanese patients at a single institute[J]. J Clin Exp Hematop,2013,53(1):69-77.
  • 5Dispenzieri A,Armitage JO,Loe MJ,et al. The clinical spectrum of Castleman’s disease[J]. Am J Hematol,2012,87(11):997-1002.
  • 6Casper C,Teltsch DY,Robinson D Jr,et al. Clinical characteristics and healthcare utilization of patients with multicentric Castleman disease[J].Br J Haematol,2015,168(1):82-93.
  • 7van Rhee F,Wong RS,Munshi N,et al. Siltuximab for multicentric Castleman’s disease:a randomised,double-blind,placebo-controlled trial[J]. Lancet Oncol,2014,15(9):966-974.
  • 8Nishimoto N,Kanakura Y,Aozasa K,et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease[J].Blood,2005,106(8):2627-2632.
  • 9Leger-Ravet MB,Peuchmaur M,Devergne O,et al. Interleukin-6 gene expression in Castleman’s disease[J]. Blood,1991,78(11):2923-2930.
  • 10Fajgenbaum DC,van Rhee F,Nabel CS. HHV-8-negative,idiopathic multicentric Castleman disease:novel insights into biology,pathogenesis,and therapy[J]. Blood,2014,123(19):2924-2933.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部